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1 Malta Council for Science and
Technology (MCST)
In 2011, the Malta Council for Science and Technol-
ogy (MCST) commissioned the Development of a dedi-
cated strategy for health research and innovation in line
with its mandate from Government to identify areas
of national priority and design and to also implement
strategic approaches to enhance economic competitive-
ness and quality of life.
The Strategy was drawn up by a steering group which
also included people from outside the health sector, to
ensure that it also keeps note of the economic side of
things.
2 Mission and Vision
The Health Research and Innovation Strategy for Malta
aims to develop an enabling health research and innova-
tion ecosystem as a springboard for securing sustainable
health care. This can be done through the identifica-
tion of areas and opportunities for undertaking health
research in processes, diagnoses, treatments and deliv-
ery of health care services.
The objective is to improve the effectiveness and effi-
ciency in these areas, attracting investment and achiev-
ing long-term sustainability.
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3 Enhancing the efficiency and
effectiveness of health care
Health research and innovation generate a range of di-
rect and indirect benefits leading to the enhancement of
the efficiency and effectiveness of healthcare.
Health research and innovation enhances the quality
of health services through the development of new and
innovative healthcare systems. Research leads to the im-
plementation of evidence-based measures and policies,
which are aimed at enhancing the quality of life of soci-
ety in general. Improvement in health system is however
a partial although direct impact of health research.
Environmental, social and economic developments are
considered as indirect impacts which contribute to ad-
vancements in the welfare system. Health Research
should cover a wide spectrum of academic fields in order
to be effective. Fields include social sciences, engineer-
ing, agriculture and food technology among others.
4 Economic growth through
health research
Health research in Malta promotes economic growth
in the long-term, particularly because it tackles demo-
graphic challenges. Despite the smallness and inherent
disadvantages faced by the Maltese economy, the devel-
opment of health research in Malta is deemed to be eco-
nomically viable especially when considering the chal-
lenges brought about by demographic development.
Smallness may actually be advantageous for local re-
searchers, if they specialize on specific niches which are
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not easily accessible in larger countries. Furthermore,
health research is expected to enhance the potential of
the Maltese economy, diversifying local economic activ-
ity. Research improved productivity within the economy
while reducing healthcare costs and increasing health-
care effectiveness.
Policy-makers in Malta should seek to encourage the
uptake of promising markets, particularly those related
to innovation, which open up new opportunities for the
local economy. The aim of the Strategy is to ensure
that health research activity and innovation in health
care is promoted and furthered in Malta. In addition,
the Strategy promoted measures that help in bridging
the gap between research and policy implementation.
The implementation of this Strategy involves a num-
ber of economic benefits, which are identified and mon-
itored through various indicators. Such benefits include
prevention through increased awareness of diseases, en-
hanced efficiency within the healthcare system, and in-
creased profits for the manufacturing sector.
In addition, capacity building and knowledge bene-
fits are improved through research results and the more
research capacity available (it increases as more institu-
tions involve themselves in research projects). Health
benefits include the improvement of the healthcare sys-
tem as well as the well-being of the citizens.
Health research is a financially worthwhile investment
as it will attract more local and international firms
to the industry. Indicators are also useful to identify
whether the resources involved are being used optimally.
5 Promoting Long-Term Sus-
tainability
The Strategy identifies the most prominent areas and
opportunities for health research and innovation, and
the investments required to develop a vibrant health re-
search and innovation ecosystem. This will provide the
springboard for improvements within the local health-
care system, taking into account the structures that are
already in place including the relevant infrastructure,
policies and initiatives.
Long-term sustainability in the health sector is an im-
portant target for this Strategy and the main recom-
mendation is the setting up of a National Research and
Innovation Centre. Sustainability is expected to be at-
tained through a range of capacity-building measures
implemented in the short, medium and long-term.
Research will focus on enhancing the efficiency and
effectiveness of processes, diagnosis, treatments and the
delivery of healthcare services. This way, the maximum
social and economic benefits from the strategy can be
attained.
6 Funding Opportunities
Future economic growth depends on reforms in various
economic sectors including health. Research is an essen-
tial component for change. Given the limited availabil-
ity of local funding, the Health Research and Innova-
tion Strategy recommends a strong internationalization
drive, based mainly on proactive participation in the rel-
evant EU funding programmes and related international
activities. This would enable local organizations and in-
dividuals to increase and achieve their potential.
The success of the health research and innovation
strategy depends primarily on the amount of funds allo-
cated by the government and the private sector, together
with the availability of additional funding provided at
an EU Level. This funding (at EU Level) includes the
FP7 programme (to be followed by Horizon 2020), the
European Social Fund (ESF), European Regional De-
velopment Fund (ERDF) and related programmes in-
cluding the Interreg and the MED Programmes.
Hence, research funds have to be secured and allocated
accountably. Funds are also needed to generate the re-
quired skills for any potential future growth of health
research industry in Malta. It is therefore important to
build, strengthen and sustain human and physical ca-
pacity to conduct, absorb and utilize health research.
7 Four main goals of the Strategy
The Strategy sets out four goals which, if implemented
within the specified timeframe, will result in an inno-
vative, efficient and effective health research strategy in
Malta.
These goals are:
i. Developing a vibrant and sustainable health research
and innovation ecosystem
ii. Building the necessary capacity and competence for
high quality research to improve well-being
iii. Supporting evidence-based policy-making in human
health and ensuring outreach and take-up
iv. Leveraging internationalisation opportunities for
economic growth and innovation in the health sector
8 Ten Key Recommendations to
achieve these goals:
For Goal 1 - Towards a vibrant and sustainable health
research and innovation ecosystem
(i) Set up a National Governance Framework
for Health Research and Innovation: to oversee
the development of an enabling ecosystem for health
research and innovation.
(ii) Increase Funding for Health Research and
Innovation: to drive capacity-building of the sector
which supports an appropriate balance of specialization
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and interdisciplinarity and coves transnational research
in a variety of disciplines in meeting societal challenges.
(iii) Ensure enhanced access to health research
facilities: and also enable researchers to network be-
tween each other as well as join international research
networks)
(iv) Enhance use of public procurement to
stimulate Research and Innovation:
a. Encourage proactive use of EU public procurement
directives as a means for stimulating public and private
sector investments in health research and innovation.
b. Enhance the role of the Public Service (both as a
purchaser and regulator) as early user of health innova-
tive products by developing capacities for implementing
public procurement for research and innovation.
c. Support the Public Service to act as a catalyst
in private procurement, through the establishment of
credit guarantees for innovative health services, training
in innovative procurement techniques and intellectual
property protection, and the purchase for private use of
innovative services and products.
For Goal 2: Building the necessary capacity and com-
petence for high quality research to improve well-being
(v) Attract high quality researchers:
a. Provide a set of attractive conditions to increase
the number and profile of local researchers engaged
in medical and health research and to attract high
quality researchers from overseas, particularly, in areas
of national priority.
b. Develop an enabling environment conducive to
research, through the establishment of an excellent
health research management system
(vi) Support Capacity-building and forward
planning
a. Map current research capacity and competence by
area in order to project current research strengths,
locally and abroad, and as a means to define better
future needs for capacity-building.
b. Facilitate forward planning by tertiary institutions
at post-graduate, doctoral and post-doctoral level to
build critical mass and develop defined and structured
research units.
c. Encourage postgraduate and doctoral level studies
and research in health through well-designed pro-
grammes and incentives.
(vii) Build critical mass and enhancing potential
of researchers:
a. Set up incentives to encourage clustering of re-
searchers from various fields including ICT, medical
and engineering.
b. Encourage the setup of Knowledge Transfer Part-
nerships (KTP) between academic institutions and
industrial partners (both local and foreign) to encourage
rewarding collaborations with innovative businesses as
well as gain ideas for further research and development
of projects.
For Goal 3: Supporting evidence-based policy making
in human health: outreach and take-up
(viii) Ensure dissemination and take-up of re-
sults:
a. Increase the publication and dissemination of re-
search findings in peer-reviewed and non-peer-reviewed
journals
b. Build the competence for communication and
exploitation of research results to develop new tools
and research applications to improve the health of the
population.
c. Utilise results as an educational tool to change the
habits, behaviour and opinion of the general public on
health issues.
(ix) Enable access to research results and new
knowledge:
a. Enable access to research results and the transfer of
knowledge needs to be improved to ensure that research
evidence is transformed into practice
b. Integrate and validate data obtained from routine
clinical examinations and investigations.
c. Set up an online portal to disseminate information
and research evidence.
d. Introduce compulsory training in entrepreneurship.
For Goal 4: Leveraging internationalisation opportuni-
ties for economic growth and innovation in the health
sector
(x) Invest in competitiveness and job creation:
a. Study and design a competitive package of policy
measurements and incentives to target local and foreign
investment in particular niche areas.
b. Review the full range of internationalisation oppor-
tunities instrumental in addressing the Strategy’s objec-
tives.
c. Ensure a strong national drive to coordinate health,
biotech and life science initiatives which exploit Malta’s
competitive advantage.
d. Increase private sector awareness of the value-added
gained from investments in research and innovation to
enhance competitiveness.
e. Introduce compulsory training in entrepreneurship
and related hands-on experience.
9 The Importance of Good Gov-
ernance
In order to ensure the set-up and implementation of the
Strategy, good governance and stewardship are neces-
sary. These are important not only to establish a vision
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for national health research, but also to identify the ap-
propriate health research priorities and research part-
nerships with the relevant international organisations,
especially those established in the EU. Good governance
is ensured if ethical standards for health research are es-
tablished and monitored.
10 Concluding Remarks
The National Strategy for Health Research and
Innovation will only succeed if there is enhanced
communication among all the main stakeholders. There
is an urgent need for a more proactive and dynamic
approach in health research and innovation.
Many clinicians and researchers feel the need to
own research-it has to be a bottom up approach. The
enabling research and innovation ecosystem needs to be
put in place as the basis for implementing the Strategy.
This ecosystem will facilitate the transformation of
research outcomes in innovative products and services
on the local as well as international market.
Malta needs to identify its Unique Selling
Propositions-Malta is ideal as a centre for pilot
projects in health care, such as bio banking, testing
new drugs, servicing clinical trials and health tourism.
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